Corgentech, Inc. (CGTK) And AlgoRx Pharmaceuticals, Inc. Complete Merger Creating Late-Stage Company Addressing Pain Management And Inflammation
12/16/2005 10:27:46 AM
More...
|
Corgentech, Inc. (CGTK) And AlgoRx Pharmaceuticals, Inc. Complete Enrollment For Phase 1/2 Trial Of Avrina(TM), New Drug Candidate For Eczema
12/6/2005 10:46:14 AM
More...
|
AlgoRx Pharmaceuticals, Inc. And Corgentech, Inc. (CGTK) To Webcast Presentation From The Lazard Capital Markets 2005 Life Sciences Conference
11/22/2005 10:53:38 AM
More...
|
Corgentech, Inc. (CGTK) And AlgoRx Pharmaceuticals, Inc. To Mail Definitive Proxy For Proposed Merger
11/17/2005 10:21:10 AM
More...
|
AlgoRx Pharmaceuticals, Inc. And Corgentech, Inc. (CGTK) Announce Addition Of Ninth Board Member To Proposed Board Of Directors For Combined Company
11/15/2005 10:46:40 AM
More...
|
Corgentech, Inc. (CGTK) And AlgoRx Pharmaceuticals, Inc. Announce Positive Data From Second Of Two Phase 3 Trials Of ALGRX 3268
11/8/2005 10:32:57 AM
More...
|
AlgoRx Pharmaceuticals, Inc. And Corgentech, Inc. (CGTK) To Webcast Presentations From Two Upcoming Investor Conferences
11/2/2005 10:32:15 AM
More...
|
Corgentech, Inc. (CGTK) And AlgoRx Pharmaceuticals, Inc. Complete Enrollment For Phase 1/2 Trial Of Avrina, New Drug Candidate For Eczema
10/27/2005 11:12:36 AM
More...
|
AlgoRx Pharmaceuticals, Inc. And Corgentech, Inc. (CGTK) Announce Positive Phase 2 Data In Patients With Morton's Neuroma
10/19/2005 5:13:22 PM
More...
|
AlgoRx Pharmaceuticals, Inc. And Corgentech, Inc. (CGTK) Announce Positive Data From Phase 3 Trial Of ALGRX 3268
10/19/2005 5:13:18 PM
More...
|
|